Harbor Investment Advisory’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746 Hold
30
﹤0.01% 1247
2026
Q1
$420 Hold
30
﹤0.01% 1182
2025
Q4
$337 Hold
30
﹤0.01% 1196
2025
Q3
$347 Hold
30
﹤0.01% 1152
2025
Q2
$367 Hold
30
﹤0.01% 1146
2025
Q1
$430 Hold
30
﹤0.01% 1142
2024
Q4
$478 Hold
30
﹤0.01% 1113
2024
Q3
$721 Hold
30
﹤0.01% 1110
2024
Q2
$598 Hold
30
﹤0.01% 1125
2024
Q1
$597 Hold
30
﹤0.01% 1253
2023
Q4
$673 Hold
30
﹤0.01% 1100
2023
Q3
$607 Hold
30
﹤0.01% 1118
2023
Q2
$767 Hold
30
﹤0.01% 1267
2023
Q1
$892 Hold
30
﹤0.01% 1263
2022
Q4
$812 Hold
30
﹤0.01% 1267
2022
Q3
$1K Hold
30
﹤0.01% 1261
2022
Q2
$1K Hold
30
﹤0.01% 1281
2022
Q1
$1K Hold
30
﹤0.01% 1285
2021
Q4
$1K Hold
30
﹤0.01% 1255
2021
Q3
$1K Hold
30
﹤0.01% 1263
2021
Q2
$1K Hold
30
﹤0.01% 1211
2021
Q1
$1K Hold
30
﹤0.01% 1207
2020
Q4
$1K Hold
30
﹤0.01% 1140
2020
Q3
$1K Sell
30
-9
-23% -$288 ﹤0.01% 1062
2020
Q2
$1K Hold
39
﹤0.01% 1042
2020
Q1
$1K Hold
39
﹤0.01% 957
2019
Q4
$1K Buy
+39
New +$1.41K ﹤0.01% 801

Other funds holding AVNS

Harbor Investment Advisory's AVNS Position: Q2 2026 in Review

Harbor Investment Advisory held its Avanos Medical (AVNS) position steady in Q2 2026 at 30 shares worth $746. The position accounts for ﹤0.01% of the portfolio, ranked #1247.

Harbor Investment Advisory first reported a position in AVNS in Q4 2019 and has held it in 27 quarters since. The position peaked at $1K in Q3 2022. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Harbor Investment Advisory held 30 shares of Avanos Medical worth $746 as of Q2 2026.
  • Harbor Investment Advisory left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1247 holding.
  • Harbor Investment Advisory first reported a position in Avanos Medical in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's Avanos Medical position peaked at $1K in Q3 2022.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.